Awardee OrganizationCASE WESTERN RESERVE UNIVERSITY
Description
Abstract Text
In spite of its importance as a potential target for disease
control, the insect gut has received little attention. Insect-borne
parasites of human disease frequently initiate their development in the
insect by penetrating its gut. The gut of hematophagous insects is also
the site of blood digestion, a process that triggers egg production and
ultimately influences insect fitness and reproduction. This proposal is
to develop molecular approaches for the study of the Simulium gut,
focusing on the above-mentioned processes.
Simulium (blackfly) is the vector for onchocerciasis (river
blindness), a debilitating disease that affects millions of people in
Africa and Latin America. The parasite is ingested by the blackfly with
the blood meal from an infected individual. In order to develop, the
parasite must penetrate the blackfly gut. Penetration is largely but not
entirely hindered by the secretion by the gut epithelium of a thick
peritrophic matrix (PM) that surrounds the blood meal. There are reasons
to believe that inhibition of PM formation would result in excessive
parasite burden which causes fly lethality. One goal of the proposed
research is to clone the genes encoding the two major PM components. The
structural organization of these genes, including essential promoter
elements, Will be defined and factors required for the gut-specific
regulation of gene expression will be investigated. A second focus of
this research is the investigation of genes which function in the
digestion of the blood meal. Two genes which were previously isolated in
this laboratory and encode putative proteolytic enzymes, will be
similarly characterized. Finally, antibodies to Simulium gut proteins
will be produced and used to explore the feasibility of developing
immunological approaches to alter the fitness of the fly or to modify its
vector capacity. The ultimate goal of these experiments is to provide
the means for devising rational approaches of vector and disease control.
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
077758407
UEI
HJMKEF7EJW69
Project Start Date
01-August-1991
Project End Date
31-May-1996
Budget Start Date
01-June-1994
Budget End Date
31-May-1995
Project Funding Information for 1994
Total Funding
$185,890
Direct Costs
$123,106
Indirect Costs
$62,784
Year
Funding IC
FY Total Cost by IC
1994
National Institute of Allergy and Infectious Diseases
$185,890
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI031478-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI031478-04
Patents
No Patents information available for 5R01AI031478-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI031478-04
Clinical Studies
No Clinical Studies information available for 5R01AI031478-04
News and More
Related News Releases
No news release information available for 5R01AI031478-04
History
No Historical information available for 5R01AI031478-04
Similar Projects
No Similar Projects information available for 5R01AI031478-04